Empagliflozin Improves Heart Failure Caused by Pressure Overload by Regulating Cardiac Metabolism

被引：0
|
作者：
Li, Xuan
Liu, Jia
Ren, Di
Zhang, Jingwen
Han, Ying
Li, Ji
机构：
来源：
CIRCULATION | 2019年 / 140卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A10294
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [31] Empagliflozin directly improves diastolic function in human heart failure
    Pabel, S.
    Bollenberg, H.
    Bengel, P.
    Tirilomis, P.
    Mustroph, J.
    Wagner, S.
    Fischer, T.
    Streckfuss-Boemeke, K.
    Maier, L.
    Hasenfuss, G.
    Hamdani, N.
    Sossalla, S.
    EUROPEAN HEART JOURNAL, 2018, 39 : 284 - 285
  • [32] Empagliflozin improves kidney outcomes in patients with heart failure and CKD
    Ellen F. Carney
    Nature Reviews Nephrology, 2021, 17 : 14 - 14
  • [33] Empagliflozin improves not only Heart Failure but also Kidney Function
    Lichert, Frank
    AKTUELLE KARDIOLOGIE, 2021, 10 (03) : 180 - 182
  • [34] Exercise training improves cardiac function and regulates myocardial mitophagy differently in ischaemic and pressure-overload heart failure mice
    Guo, Chen
    Chen, Meng-Jie
    Zhao, Jin-Rui
    Wu, Rui-Yun
    Zhang, Yue
    Li, Qiang-Qiang
    Zhao, Hong
    Dou, Jia-Hao
    Song, Shou-Fang
    Wei, Jin
    EXPERIMENTAL PHYSIOLOGY, 2022, 107 (06) : 562 - 574
  • [35] A Heart Failure Model Established by Pressure Overload Caused by Abdominal Aortic Contraction in Rat
    Dai, Wang Sheng
    Chen, YuKun
    Lin, ShiHao
    Chen, Qiang
    Cao, Hua
    DISEASE MARKERS, 2022, 2022
  • [36] Endothelial p53 Deletion Improves Angiogenesis and Prevents Cardiac Fibrosis and Heart Failure Induced by Pressure Overload in Mice
    Gogiraju, Rajinikanth
    Xu, Xingbo
    Bochenek, Magdalena L.
    Steinbrecher, Julia H.
    Lehnart, Stephan E.
    Wenzel, Philip
    Kessel, Michael
    Zeisberg, Elisabeth M.
    Dobbelstein, Matthias
    Schaefer, Katrin
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2015, 4 (02):
  • [37] Long-term empagliflozin treatment improves cardiac function and remodeling in rats with chronic heart failure
    Stephan, Y.
    Soulie, M.
    Peschanski, N.
    Nicol, L.
    Henry, J. P.
    Richard, V.
    Pieper, M. P.
    Mulder, P.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 284 - 284
  • [38] Treatment with the SGLT2 inhibitor empagliflozin improves cardiac function in rats with chronic heart failure
    Soulie, M.
    Stephan, Y.
    Nicol, L.
    Henry, J. -P.
    Richard, V.
    Pieper, M. P.
    Mulder, P.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S436 - S436
  • [39] Short and Long-term Empagliflozin Treatment Improves Cardiac Function in Rats with Chronic Heart Failure
    Soulie, M.
    Stephan, Y.
    Nicol, L.
    Henry, J. P.
    Richard, V.
    Pieper, M.
    Mulder, P.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 30 - 30
  • [40] Empagliflozin improves aortic injury in obese mice by regulating fatty acid metabolism
    Yue, Lin
    Wang, Yue
    Wang, Cuiying
    Niu, Shu
    Dong, Xihong
    Guan, Yaqing
    Chen, Shuchun
    OPEN MEDICINE, 2024, 19 (01):
12345